Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs

Cancer Prevention Research

Volumn 3, Issue 1, 2010, Pages 62-72

  Izzotti, Alberto ^a   Calin, George A ^b   Steele, Vernon E ^c   Cartiglia, Cristina ^a   Longobardi, Mariagrazia ^a   Croce, Carlo M ^d   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ACETYLCYSTEINE; BETA NAPHTHOFLAVONE; CIGARETTE SMOKE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; OLTIPRAZ; PHENETHYL ISOTHIOCYANATE; PROTEIN P53; RAS PROTEIN; TRANSFORMING GROWTH FACTOR; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; ISOTHIOCYANIC ACID DERIVATIVE; PYRAZINE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFICACY; LUNG CANCER; MALE; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; ANIMAL; BIOSYNTHESIS; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION; LUNG; METHODOLOGY; PASSIVE SMOKING; PRINCIPAL COMPONENT ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ANIMALS; ANTICARCINOGENIC AGENTS; BETA-NAPHTHOFLAVONE; CHEMOPREVENTION; CLUSTER ANALYSIS; ENZYME INHIBITORS; GENE EXPRESSION; INDOLES; ISOTHIOCYANATES; LUNG; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOBACCO SMOKE POLLUTION;

EID: 77649196362     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0202     Document Type: Article

References (48)

1. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290-7.
2. Xu P, Guo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genet 2004;20:617-24.
3. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science 2005;310:1288-9.
4. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-6.
5. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic-islet specific miRNA regulates insulin secretion. Nature 2004;432:226-30.
6. Couzin J. MicroRNAs make big impression in disease after disease. Science 2008;319:1782-4.
7. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
8. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med 2006;12:580-7.
9. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006;66:7390-4.
10. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Down-regulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009;23:806-12.
11. Schembri F, Sridhar S, Perdomo C, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 2009;106:2319-24.
12. Izzotti A, Calin GA, Steele VE, Croce CM, De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 2009;23:3243-50.
13. Trosko JE, Upham BL. The emperor wears no clothes in the field of carcinogenic risk assessment: ignored concepts in cancer risk assessment. Mutagenesis 2005;20:81-92.
14. Upham BL, Trosko JE. Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression. Antioxid Redox Signal 2009;11:1-11.
15. Izzotti A, Bagnasco M, Cartiglia C, et al. Modulation of multigene expression and proteome profiles by chemopreventive agents. Mutat Res 2005;591:212-23.
16. Izzotti A, Bagnasco M, Cartiglia C, et al. Chemoprevention of genome, transcriptome, and proteome alterations induced by cigarette smoke in rat lung. Eur J Cancer 2005;41:1864-74.
17. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
18. Zong Q, Schummer M, Hood L, Morris DR. Messenger RNA translation state: the second dimension of high-throughput expression screening. Proc Natl Acad Sci U S A 1999;96:10632-6.
19. Melton L. Proteomics in multiplex. Nature 2004;429:101-7.
20. Pinkerton KE, Joad JP. Influence of air pollution on respiratory health during perinatal development. Clin Exp Pharmacol Physiol 2006;33: 269-72.
21. Izzotti A, Cartiglia C, Longobardi M, et al. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB J 2004;18:1559-61, (Full text published online, 2 August 2004).
22. Yao R, Wang Y, Lubet RA, et al. K-Ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. Exp Lung Res 2005; 31:271-81.
23. De Flora S, Balansky RM, D'Agostini F, et al. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer Res 2003;63:793-800.
24. Izzotti A, Cartiglia C, Longobardi M, et al. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke. Cancer Res 2004;64:8566-72.
25. D'Agostini F, Izzotti A, Balansky RM, Bennicelli C, De Flora S. Modulation of apoptosis by chemopreventive agents. Mutat Res 2005;591:173-86.
26. Gerald D, Berra E, Frapart YM, et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004;118:781-94.
27. Zhao F, Nozawa H, Daikonnya A, Kondo K, Kitanaka S. Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biol Pharm Bull 2003;26:61-5.
28. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001;20:2927-36.
29. Mi L, Xiao Z, Hood BL, et al. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem 2008;283:22136-46.
30. De Flora S, Izzotti A, D'Agostini F, Balansky RM. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001;22:999-1013.
31. De Flora S, Izzotti A, Albini A, D'Agostini F, Bagnasco M, Balansky RM. Antigenotoxic and cancer preventive mechanisms of N-acetyl-L- cysteine. In: Kelloff GJ, Hawk ET, Sigman CC, editors. Cancer chemoprevention. 1. New York: The Humana Press Inc.; 2004, p. 37-67.
32. Madhukar BV, Dimitrov NV, Meyer-Leece C, Contreras ML, Crowell J. Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz. Mol Cancer Ther 2002;1:1125-8.
33. Chi WJ, Doong SL, Lin-Shiau SY, Boone CW, Kelloff GJ, Lin JK. Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein. Carcinogenesis 1998;19:2133-8.
34. Kang KW, Choi SH, Ha JR, Kim CW, Kim SG. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2- dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-β1 and tumor necrosis factor-α expression. Chem Biol Interact 2002;139:61-77.
35. Hu R, Kim BR, Chen C, Hebbar V, Kong AN. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003;24:1361-7.
36. Kong AN, Owuor E, Yu R, et al. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 2001;33:255-71.
37. Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 2006;10:241-52.
38. Hsu JC, Dev A, Wing A, Brew CT, Bjeldanes LF, Firestone GL. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem Pharmacol 2006;72:1714-23.
39. Brew CT, Aronchik I, Hsu JC, et al. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer 2006;118:857-68.
40. Xiang B, Chatti K, Qiu H, et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc Natl Acad Sci U S A 2008; 105:12463-8.
41. López-Malpartida AV, Ludeña MD, Varela G, Pichel JG. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas. Lung Cancer 2009;65:25-33.
42. Rahman KM, Aranha O, Glazyrin A, Chinni SR, Sarkar FH. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells. Oncogene 2000;19: 5764-71.
43. Sevignani C, Calin GA, Nnadi SC, et al. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A 2007;104:8017-22.
44. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007;104:3300-5.
45. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007;16:1124-31.
46. Van Schooten FJ, Nia AB, De Flora S, et al. Effects of oral N-acetylcysteine: a multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev 2002;11:167-75.
47. Seow A, Vainio H, Yu MC. Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat Res 2005;592:58-67.
48. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008;29:1306-11.